Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

ImClone Systems earns manufacturing milestone from Merck KGaA

Aug. 4, 1997

GnRH conjugate vaccines prepared at Merck & Co.

July 30, 1997

FDA advisory committee recommends approval of rituximab

July 28, 1997

Bristol-Myers Squibb licenses cancer vaccines from Progenics

July 18, 1997

Low-dose interferon alfa nears phase III for the treatment of Sjogren's syndrome

July 17, 1997

Maxamine enters phase III for malignant melanoma

July 15, 1997

Jenner Technologies reports results from phase I/II trial of prostate cancer vaccine

July 9, 1997

MDX-210 shows promise in advanced kidney and prostate cancer

July 1, 1997

Ajinomoto prepares peptides for treating or preventing human gastric cancer

June 30, 1997

Novopharm Biotech issued U.S. patent for two human monoclonal antibodies

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...